计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| R129674-10mg |
10mg |
现货 ![]() |
| |
| R129674-50mg |
50mg |
现货 ![]() |
| |
| R129674-250mg |
250mg |
现货 ![]() |
| |
| R129674-1g |
1g |
现货 ![]() |
|
| 别名 | 咯利普兰 | 4-[3-(环戊氧基)-4-甲氧基苯基]-2-吡咯烷酮 |
|---|---|
| 英文别名 | BDBM14361 | BRN 1588548 | Tox21_110672 | KBio2_000076 | MLS000759531 | Opera_ID_1749 | BCP23388 | KBio2_005212 | SR-01000000162 | GTPL5260 | HMS1791D18 | KBio2_002644 | KS-1400 | Pharmakon1600-01505683 | Rolipramum | SMR000058510 | BPBio1_000912 | HMS2097 |
| 规格或纯度 | Moligand™, ≥97% |
| 英文名称 | Rolipram |
| 生化机理 | 罗利普仑是一种选择性、细胞渗透性的 cAMP 特异性 PDE(磷酸二酯酶)(PDE4,IC50=1 μM)抑制剂。研究表明,该化合物能抑制人体海绵体组织中 PDE4 的活性,从而中断勃起反应的信号转导途径。罗利普仑通过一种 cAMP 依赖性机制促进 HL60 细胞的凋亡,并被证明能提高神经元的存活率。罗利普仑是 PDE4A1 和 PDE4B 的抑制剂。选择性 cAMP 特异性磷酸二酯酶 PDE4 抑制剂(抑制小鼠 PDE4A1 和 PDE4B 的 IC 50 值分别为 1.1 和 0.17 μM) |
| 储存温度 | -20°C储存 |
| 运输条件 | 超低温冰袋运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 磷酸二酯酶 4A 抑制剂;磷酸二酯酶 4B 抑制剂;磷酸二酯酶 4C 抑制剂;磷酸二酯酶 4D 抑制剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
A selective, cell permeable inhibitor of cAMP-specific phosphodiesterase (PDE4). Rolipram enhances tissue protection, anatomical repair and functional recovery. It is used to treat asthma, arthritis, Huntington′s disease and multiple sclerosis. Rolipram inhibits injury-induced reductions in cyclic AMP, which is associated with acute central nervous system injury. It functions as an antidepressant, stimulates neurite outgrowth and axonal regeneration in the presence of myelin inhibitors. |
| 纯度 | ≥97% |
| ALogP | 2.2 |
|---|
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
| PubChem SID | 504750844 |
|---|---|
| EC号 | 262-771-1 |
| 分子类型 | 小分子 |
| IIUPAC Name | 4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one |
| INCHI | 1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18) |
| InChi Key | HJORMJIFDVBMOB-UHFFFAOYSA-N |
| Smiles | COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 |
| Isomeric SMILES | COC1=C(C=C(C=C1)C2CC(=O)NC2)OC3CCCC3 |
| 关联CAS | 61413-54-5 |
| PubChem CID | 5092 |
| NSC Number | 760125 |
| MeSH Entry Terms | Rolipram;ZK 62711;ZK-62711;ZK62711 |
| 分子量 | 275.34 |
| 溶解性 | Soluble in water (0.2 mg/mL ), DMSO (7.3 mg/ml ), ethanol (7 mg/ml warm), DMF (~10 mg/ml ), DMF:PBS (pH 7.2, 1:9) (~0.5 mg/ml ), and acetone (25 mg/ml). |
|---|---|
| 敏感性 | 对热敏感 |
| 熔点 | 130-134°C |
| 分子量 | 275.340 g/mol |
| XLogP3 | 2.200 |
| 氢键供体数Hydrogen Bond Donor Count | 1 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 4 |
| 精确质量Exact Mass | 275.152 Da |
| 单同位素质量Monoisotopic Mass | 275.152 Da |
| 拓扑极表面积Topological Polar Surface Area | 47.600 Ų |
| 重原子数Heavy Atom Count | 20 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 341.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 1 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| 象形图 | GHS07 |
|---|---|
| 信号词 | 警告 |
| 危险声明 |
H302: 吞食有害 H315: 引起皮肤刺激 H319: 引起严重眼睛刺激 H335: 可能引起呼吸道刺激 |
| 预防措施声明 |
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾 P264: 处理后要彻底洗手。 P270: 使用本产品时,请勿进食、饮水或吸烟。 P271: 仅在室外或通风良好的地方使用。 P280: 戴防护手套/穿防护服/戴防护眼罩/戴防护面具。 P321: 特殊处理(请参阅此标签上的...)。 P330: 漱口 P302+P352: 如皮肤沾染:用水充分清洗。 P304+P340: 如误吸入:将人转移到空气新鲜处,保持呼吸舒适体位。 P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。 P362+P364: 脱掉沾污的衣服,清洗后方可重新使用。 P405: 密闭存放 P403+P233: 存放在通风良好的地方。保持容器密闭。 P501: 将内容物/容器处理到。。。 P264+P265: 处理后彻底洗手[和…]。不要触摸眼睛。 P301+P317: 如果被吞咽:请寻求医疗帮助。 P337+P317: 如果眼睛刺激持续:寻求医疗帮助。 P332+P317: 如果出现皮肤刺激:请寻求医疗帮助。 P319: 如果你感到不适,请寻求医疗帮助。 |
| WGK Germany | 3 |
| RTECS | UY5749237 |
| Merck Index | 8251 |
| 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
¥416.72
| 1. Huang Z, Mancini JA. (2006) Phosphodiesterase 4 inhibitors for the treatment of asthma and COPD.. Curr Med Chem, 13 (27): (3253-62). [PMID:17168849] |
| 2. Normann C, Berger M. (2008) Neuroenhancement: status quo and perspectives.. Eur Arch Psychiatry Clin Neurosci, 258 Suppl 5 (110-4). [PMID:18985306] |
| 3. García-Osta A, Cuadrado-Tejedor M, García-Barroso C, Oyarzábal J, Franco R. (2012) Phosphodiesterases as therapeutic targets for Alzheimer's disease.. ACS Chem Neurosci, 3 (11): (832-44). [PMID:23173065] |
| 4. Kumar N, Goldminz AM, Kim N, Gottlieb AB. (2013) Phosphodiesterase 4-targeted treatments for autoimmune diseases.. BMC Med, 11 (96). [PMID:23557064] |
| 5. Ahmad F et al.. (2021) Chemical Stimulation of Rodent and Human Cortical Synaptosomes: Implications in Neurodegeneration.. Cells, 10 (5): [PMID:34065927] |
| 6. Severino J et al.. (2022) Controlled X-chromosome dynamics defines meiotic potential of female mouse in vitro germ cells.. EMBO J, 41 (12): (e109457). [PMID:35603814] |
| 7. Shelly M et al.. (2010) Local and long-range reciprocal regulation of cAMP and cGMP in axon/dendrite formation.. Science, 327 (5965): (547-52). [PMID:20110498] |
| 8. Murase Y et al.. (2020) Long-term expansion with germline potential of human primordial germ cell-like cells in\xa0vitro.. EMBO J, 39 (21): (e104929). [PMID:32954504] |
| 9. Nelissen E et al.. (2021) Soluble Guanylate Cyclase Stimulator Vericiguat Enhances Long-Term Memory in Rats without Altering Cerebral Blood Volume.. Biomedicines, 9 (8): [PMID:34440254] |
| 10. Nelissen E et al.. (2022) The sGC stimulator BAY-747 and activator runcaciguat can enhance memory in vivo via differential hippocampal plasticity mechanisms.. Sci Rep, 12 (3589). [PMID:35246566] |
| 11. Youzhi Wang, Huifang Wang, Guoqing Yang, Qingjing Hao, Kan Yang, Huizhen Shen, Yulong Wang, Jinxin Wang. (2023) Design and synthesis of a novel class of PDE4 inhibitors with antioxidant properties as bifunctional agents for the potential treatment of COPD. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 256 (115374). [PMID:37150057] [10.1016/j.ejmech.2023.115374] |
| 12. You-Zhi Wang, Yu-Long Wang, Hao-Jie Che, Yi-He Jia, Hui-Fang Wang, Lin-Fei Zuo, Kan Yang, Ting-Ting Li, Jin-Xin Wang. (2023) Sappanone A: A natural PDE4 inhibitor with dual anti-inflammatory and antioxidant activities from the heartwood of Caesalpinia sappan L.. JOURNAL OF ETHNOPHARMACOLOGY, 304 (116020). [PMID:36529254] [10.1016/j.jep.2022.116020] |
| 13. Zhuo-Er Qiu, Lei Chen, Xiao-Chun Hou, Jie Sheng, Jian-Bang Xu, Jia-Wen Xu, Dong-Dong Gao, Ze-Xin Huang, Tian-Lun Lei, Zi-Yang Huang, Lei Peng, Hai-Long Yang, Qin-Hua Lin, Yun-Xin Zhu, Wei-Jie Guan, Zhao-Rong Lun, Wen-Liang Zhou, Yi-Lin Zhang. (2023) Toxoplasma gondii infection triggers ongoing inflammation mediated by increased intracellular Cl− concentration in airway epithelium. JOURNAL OF INFECTION, 86 (47). [PMID:36334726] [10.1016/j.jinf.2022.10.037] |
| 14. Minchi Liu, Wenjun Qian, Selvaraj Subramaniyam, Shuang Liu, Wenkuan Xin. (2020) Denatonium enhanced the tone of denuded rat aorta via bitter taste receptor and phosphodiesterase activation. EUROPEAN JOURNAL OF PHARMACOLOGY, 872 (172951). [PMID:32006560] [10.1016/j.ejphar.2020.172951] |